Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Albuquerque Monteiro (Coimbra, Portugal), A. Cruz e Costa (Coimbra, Portugal). Family screening in alpha1-antitrypsin deficiency. 572

Member's Comments

No comment yet.

Related content which might interest you: Identification of individuals with alpha-1-antitrypsin deficiency by a targeted screening program Source: Annual Congress 2007 - Lung function and therapy in obstructive lung diseases Year: 2007 Diagnosis and management of alpha1-antitrypsin deficiency Source: Breathe 2007; 4: 38-46 Year: 2007 Implementation of screening program for alpha-1 antitrypsin deficiency in Spain Source: Annual Congress 2004 - Emphysema and oxygen therapy Year: 2004 Hereditary alpha1-antitrypsin deficiency in children and its clinical consequences Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013 The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in Polish population – Results from the ongoing newborn screening Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 Occupational exposure in alpha-1-antitrypsin deficiency (AATD) Source: Annual Congress 2008 - COPD and other environment-related lung diseases Year: 2008 Health status changes in patients with alpha-1-antitrypsin deficiency Source: Eur Respir J 2002; 20: Suppl. 38, 249s Year: 2002 Bronchiectasis in alpha1-antitrypsin deficiency Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions Year: 2019 The Irish national alpha-1 antitrypsin deficiency targeted detection programme Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013 What we have learned about alpha-1-antitrypsin deficiency Source: Virtual Congress 2021 – Rare lung diseases 2021 Year: 2021 Clinical phenotype of individuals with common COPD investigated during the targeted detection programme for alpha1-antitrypsin deficiency in Italy Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007 Screening of alpha-1 antitrypsin deficiency in a blood donors cohort of the North-Italian area Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015 Pulmonary administration of alpha1-antitrypsin for the treatment of Alpha1-antitrypsin deficiency Source: Eur Respir J 2003; 22: Suppl. 45, 385s Year: 2003 The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency - results from the Austrian Alpha-1 Lung Registry Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases Year: 2021 Screening for alpha1-antitrypsin deficiency at a university hospital Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011 Molecular characterization of novel PiS-like alleles identified in Spanish patients with Alpha-1 antitrypsin deficiency Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in Polish population - results from large scale newborn screening Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD) Year: 2014 Health status changes in alpha-1-antitrypsin deficiency (PiZ phenotype) over 3 years Source: Annual Congress 2003 - Alpha-1 antitrypsin deficiency and COPD Year: 2003